KKR Invests in China Cord Blood

April 12, 2012  BY ALISON TUDOR Kohlberg Kravis Roberts & Co. L.P. will invest $65 million into China Cord Blood Corp., the country's largest operator of services for umbilical cord blood that is rich in stem cells, to capitalize on China's fast-growing health-care services industry. Listed on the New York Stock Exchange since 2009, CCBC was the first licensed cord-blood banking operator in China, providing collection, testing, processing and storage services. CCBC runs the largest cord-blood banking network in ...